ELOCTATE 1000
Država: Izrael
Jezik: angleščina
Source: Ministry of Health
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Aktivna sestavina:
COAGULATION FACTOR VIII
Dostopno od:
SANOFI - AVENTIS ISRAEL LTD
Koda artikla:
B02BD05
Farmacevtska oblika:
POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Sestava:
COAGULATION FACTOR VIII 1000 IU
Pot uporabe:
I.V
Tip zastaranja:
Required
Izdeluje:
BIOGEN IDEC LIMITED , UK
Terapevtsko območje:
COAGULATION FACTOR VII
Terapevtske indikacije:
ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.
Datum dovoljenje:
2017-01-09
